Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3047% below fair value
$79.11−1.68 (-2.08%)
Close on Nov 20, 2026Market cap $32.69BP/E 13.0Yield 2.57%
Zoetis shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Zoetis's shares outstanding was 418M at Jun 30, 2026. For fiscal 2025 it was 444M, down 2.4% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is 502M in fiscal 2014.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 444M | -2.4% |
| FY2024 | Dec 31, 2024 | 455M | -1.6% |
| FY2023 | Dec 31, 2023 | 462M | -1.7% |
| FY2022 | Dec 31, 2022 | 470M | -1.3% |
| FY2021 | Dec 31, 2021 | 477M | -0.4% |
| FY2020 | Dec 31, 2020 | 479M | -0.7% |
| FY2019 | Dec 31, 2019 | 482M | -1.0% |
| FY2018 | Dec 31, 2018 | 487M | -1.3% |
| FY2017 | Dec 31, 2017 | 493M | -1.0% |
| FY2016 | Dec 31, 2016 | 498M | -0.8% |
| FY2015 | Dec 31, 2015 | 502M | -0.0% |
| FY2014 | Dec 31, 2014 | 502M | +0.3% |
| FY2013 | Dec 31, 2013 | 500M | +0.1% |
| FY2012 | Dec 31, 2012 | 500M | 0.0% |
| FY2011 | Dec 31, 2011 | 500M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 418M | -6.2% |
| Q1 FY2026 | Mar 31, 2026 | 422M | -5.7% |
| Q4 FY2025 | Dec 31, 2025 | 439M | -2.8% |
| Q3 FY2025 | Sep 30, 2025 | 443M | -2.3% |
| Q2 FY2025 | Jun 30, 2025 | 446M | -2.3% |
| Q1 FY2025 | Mar 31, 2025 | 448M | -2.4% |
| Q4 FY2024 | Dec 31, 2024 | 451M | -2.0% |
| Q3 FY2024 | Sep 30, 2024 | 454M | -1.7% |
| Q2 FY2024 | Jun 30, 2024 | 456M | -1.5% |
| Q1 FY2024 | Mar 31, 2024 | 459M | -1.2% |
| Q4 FY2023 | Dec 31, 2023 | 460M | -1.4% |
| Q3 FY2023 | Sep 30, 2023 | 461M | -1.6% |
| Q2 FY2023 | Jun 30, 2023 | 463M | -1.8% |
| Q1 FY2023 | Mar 31, 2023 | 465M | -2.0% |
| Q4 FY2022 | Dec 31, 2022 | 467M | -1.9% |
| Q3 FY2022 | Sep 30, 2022 | 469M | -1.5% |
| Q2 FY2022 | Jun 30, 2022 | 472M | -1.2% |
| Q1 FY2022 | Mar 31, 2022 | 474M | -0.8% |
| Q4 FY2021 | Dec 31, 2021 | 476M | -0.7% |
| Q3 FY2021 | Sep 30, 2021 | 476M | -0.5% |
| Q2 FY2021 | Jun 30, 2021 | 477M | -0.2% |
| Q1 FY2021 | Mar 31, 2021 | 478M | -0.2% |
| Q4 FY2020 | Dec 31, 2020 | 479M | -0.3% |
| Q3 FY2020 | Sep 30, 2020 | 479M | -0.6% |
| Q2 FY2020 | Jun 30, 2020 | 478M | -0.9% |
| Q1 FY2020 | Mar 31, 2020 | 479M | -0.8% |
| Q4 FY2019 | Dec 31, 2019 | 480M | -0.9% |
| Q3 FY2019 | Sep 30, 2019 | 482M | -0.9% |
| Q2 FY2019 | Jun 30, 2019 | 482M | -1.1% |
| Q1 FY2019 | Mar 31, 2019 | 483M | -1.4% |
| Q4 FY2018 | Dec 31, 2018 | 484M | -1.3% |
| Q3 FY2018 | Sep 30, 2018 | 486M | -1.3% |
| Q2 FY2018 | Jun 30, 2018 | 488M | -1.3% |
| Q1 FY2018 | Mar 31, 2018 | 490M | -1.1% |
| Q4 FY2017 | Dec 31, 2017 | 491M | -1.1% |
| Q3 FY2017 | Oct 1, 2017 | 492M | -1.1% |
| Q2 FY2017 | Jul 2, 2017 | 494M | – |
| Q1 FY2017 | Apr 2, 2017 | 495M | – |
| Q4 FY2016 | Dec 31, 2016 | 497M | – |
| Q3 FY2016 | Oct 2, 2016 | 498M | – |
See a number that looks wrong?